PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Insilico Medicine Founder and CEO Alex Zhavoronkov, PhD talks about AI and robotics in healthcare breakthroughs in following conferences

Insilico Medicine Founder and CEO Alex Zhavoronkov, PhD talks about AI and robotics in healthcare breakthroughs in following conferences
2024-06-07
(Press-News.org)

Alex Zhavoronkov, PhD, founder and co-CEO of Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, will be attending a series of meetings in the following week, where he will be discussing bioscience innovations powered by AI and robotics.

More information about the events is listed as follows:

[1] London Tech Week 2024

Fireside Chat: The Forefront of AI Innovation in Health Tech

Time: Monday, 10th June 15:55 - 16:15 (UK time)

Location: London Olympia, Main Stage

London Tech Week is the global tech ecosystem aiming to accelerate the infinite cycle of tech innovation, which brings together the innovators creating the technologies of the future, the investors who fund them and the enterprise tech leaders who adopt them.

With over 90 countries represented, London Tech Week 2024 focuses on key themes including artificial intelligence, the deep tech revolution and green innovation, with 45,000 attendees gathering across the week.

[2] Founders Forum Global & Founders Longevity Forum

Session: Bioscience Breakthroughs: The Path to Healthier Lives and Longevity

Time: Thursday, 13th June, 11:25 AM - 12:05 PM (UK time)

Location: Soho Farmhouse, UK

Founders Forum Group is a global community and group of businesses empowering entrepreneurs started in 2005. Since then, it has hosted over 40 forums in more than 20 cities worldwide, hoping to foster collaboration and innovation.

In its 18th edition, Founders Forum Global 2024 connects 400+ trailblazing founders and 130 world-class VCs representing $1.5 trillion AUM, encompassing 60 sectors and 35 countries all over the world.

Fireside Chat: How AI is accelerating drug discovery, commercialization and licensing models.

Time: Monday 11 June 12:15pm (UK time)

Location: London Olympia

Designed to bring together founders and CEOs, venture capitalists, corporate venture capitalists, family offices, and global thought leaders, Founders Longevity Forum aim to establish connections and ignite innovation in the longevity tech field. In 2024, the event will be held during London Tech Week, the lively global technology gathering.

Since 2021, Insilico has nominated 18 preclinical candidates in its comprehensive portfolio of over 30 assets and has received clinical trial approval for seven molecules. In March 2024, the Company published a paper in Nature Biotechnology that discloses the raw experimental data and the preclinical and clinical evaluation of its lead drug – a potentially first-in-class TNIK inhibitor for the treatment of idiopathic pulmonary fibrosis discovered and designed using generative AI currently in Phase II trials with patients.

 

About Insilico Medicine

Insilico Medicine, a global clinical-stage biotechnology company powered by generative AI, connects biology, chemistry, and clinical trial analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and generating novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. www.insilico.co

END


[Attachments] See images for this press release:
Insilico Medicine Founder and CEO Alex Zhavoronkov, PhD talks about AI and robotics in healthcare breakthroughs in following conferences Insilico Medicine Founder and CEO Alex Zhavoronkov, PhD talks about AI and robotics in healthcare breakthroughs in following conferences 2 Insilico Medicine Founder and CEO Alex Zhavoronkov, PhD talks about AI and robotics in healthcare breakthroughs in following conferences 3

ELSE PRESS RELEASES FROM THIS DATE:

New: Classification Criteria for Hand OA

2024-06-07
Hand osteoarthritis mainly affects the distal interphalangeal, proximal interphalangeal, and thumb base joints,1 leading to joint pain, aching, and stiffness. Criteria developed by the American College of Rheumatology (ACR) in 1990 are useful, but they cannot distinguish between interphalangeal or thumb base disease, and this is important since these two phenotypes may require different treatment strategies.   To address this, EULAR and a team of leading experts in the field set out to develop new classification criteria sets that include radiographic features. Early phases of the project used observational data to identify self-reported, ...

Perturbations simplify the study of “super photons”

Perturbations simplify the study of “super photons”
2024-06-07
Thousands of particles of light can merge into a type of “super photon” under suitable conditions. Physicists call such a state a photon Bose-Einstein condensate. Researchers at the University of Bonn have now shown that this exotic quantum state obeys a fundamental theorem of physics. This finding now allows one to measure properties of photon Bose-Einstein condensates which are usually difficult to access. The study has been published in the journal Nature Communications. If many atoms are cooled to a very low temperature confined in a small volume, they can become indistinguishable and behave like a single “super particle.” Physicists also call this ...

Decoding salvia miltiorrhiza: a molecular approach to boosting bioactive compounds

Decoding salvia miltiorrhiza: a molecular approach to boosting bioactive compounds
2024-06-07
Salvia miltiorrhiza, known as Danshen, is widely used in traditional Chinese medicine for treating cardiovascular diseases, cancer, and Alzheimer's disease. The medicinal properties of Danshen are primarily attributed to its two major bioactive compounds: tanshinones and phenolic acids. Despite their importance, the genetic and regulatory mechanisms underlying their biosynthesis remain poorly understood. Based on these challenges, there is a pressing need for in-depth research to uncover the molecular pathways involved in the production of these ...

Digital babies created to improve infant healthcare

Digital babies created to improve infant healthcare
2024-06-07
Researchers at University of Galway have created digital babies to better understand infants’ health in their critical first 180 days of life. The team created 360 advanced computer models that simulate the unique metabolic processes of each baby. The digital babies are the first sex-specific computational whole-body models representing newborn and infant metabolism with 26 organs, six cell types, and more than 80,000 metabolic reactions. Real-life data from 10,000 newborns, including sex, birth weight and metabolite concentrations, enabled the creation and validation ...

Lavender's secret: genetic regulator boosts plant health and fragrance output

Lavenders secret: genetic regulator boosts plant health and fragrance output
2024-06-07
A groundbreaking study has identified a gene that plays a dual role in enhancing both the aromatic compounds and disease resistance in lavender plants. The research uncovers how the LaMYC7 gene positively regulates the biosynthesis of linalool and caryophyllene, key for lavender's scent and its resistance to common plant pathogens. Plants face various environmental pressures, including biotic stressors like pathogens and abiotic stressors such as extreme temperatures. Among biotic stressors, Pseudomonas syringae significantly threatens plant health worldwide. Terpenoids, including linalool and caryophyllene, play crucial roles in plant ...

How $4 billion funded the unprecedented COVID-19 pandemic response

How $4 billion funded the unprecedented COVID-19 pandemic response
2024-06-07
New University of Virginia School of Medicine research is shedding light on how federal funding helped scientists understand the COVID-19 virus, develop new treatments and deploy lifesaving vaccines in record time. The UVA Health researchers used advanced “machine learning” – a form of artificial intelligence – to analyze the thousands of scientific publications that resulted from the National Institutes of Health’s deployment of more than $4 billion to combat the pandemic. This analysis allowed the researchers to categorize the types ...

Advances in omics research of rosaceae

Advances in omics research of rosaceae
2024-06-07
A research team has provided a comprehensive overview of the applications of omics technologies in Rosaceae plants. The study highlights significant advancements in genome sequencing, transcriptome, proteomics, and metabolomics, shedding light on the genetic regulatory mechanisms underlying crucial traits such as flower color, fragrance, stress tolerance, and fruit quality. This research is invaluable for molecular breeding and improving economic traits in Rosaceae plants, potentially leading to the rapid cultivation of new varieties and germplasm. The Rosaceae family, with its diverse species and economic importance, is a focus ...

Basic research: Inhibition of epigenetic control enzymes in immune cells as a potential new starting point in cancer immunotherapy

2024-06-07
Immunotherapy is one of the pillars in the fight against cancer and aims to enable the body's own immune system to fight a tumor. A recent study now shows that removing certain enzymes that regulate epigenetic processes from the so-called dentritic cells of the immune system influences their development and thus improves anti-tumor immunity. This finding could lead to new therapeutic strategies in immunotherapy. The study by Cristiano De Sá Fernandes from Maria Sibilia's research group at the Center for Cancer Research and the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital was recently published in Cell Reports. Cancer cells are the body's ...

Tracking greenhouse gas emissions in Chinese value chains with an interprovincial input–output model

Tracking greenhouse gas emissions in Chinese value chains with an interprovincial input–output model
2024-06-07
China’s economy has shifted from a stage of high growth to a stage of high-quality development, and the establishment of a dual-carbon target requires profound changes in the industrial structure and energy systems, as well as finding the right direction and pathway for industrial adjustment. While the potential for technological emission reduction continues to be released, the main factor affecting China’s carbon emissions is the speed and intensity of economic transformation and industrial restructuring.   A research team of Dr. GU Alun from Tsinghua University in Beijing, China, recently analyzed the correlations ...

Earth and space share the same turbulence

Earth and space share the same turbulence
2024-06-07
Fukuoka, Japan—In a paper published in Geophysical Research Letters, researchers have discovered that the turbulence in the thermosphere exhibits the same physical laws as the wind in the lower atmosphere. Furthermore, wind in the thermosphere predominantly rotates in a cyclonic direction, in that it rotates counterclockwise in the Northern Hemisphere and clockwise in the Southern Hemisphere. The findings reveal a new unified principle for the Earth’s varied environmental systems and can potentially improve future forecasting of both earth and space weather. One time or another we’ve tuned in to see the latest weather forecast, and while ...

LAST 30 PRESS RELEASES:

Antidepressant shows promise for treating brain tumors

European Green Deal: a double-edged sword for global emissions

Walking in lockstep

New blood test could be an early warning for child diabetes

Oceanic life found to be thriving thanks to Saharan dust blown from thousands of kilometers away

Analysis sheds light on COVID-19-associated disease in Japan

Cooler heads prevail: New research reveals best way to prevent dogs from overheating

UC Riverside medical school develops new curriculum to address substance use crisis

Food fussiness a largely genetic trait from toddlerhood to adolescence

Celebrating a century of scholarship: Isis examines the HSS at 100

Key biomarkers identified for predicting disability progression in multiple sclerosis

Study: AI could lead to inconsistent outcomes in home surveillance

Study: Networks of Beliefs theory integrates internal & external dynamics

Vegans’ intake of protein and essential amino acids is adequate but ultra-processed products are also needed

Major $21 million Australian philanthropic investment to bring future science into disease diagnosis

Innovating alloy production: A single step from ores to sustainable metals

New combination treatment brings hope to patients with advanced bladder cancer

Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston

UTIA researchers win grant for automation technology for nursery industry

Can captive tigers be part of the effort to save wild populations?

The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program

Mysteries of the bizarre ‘pseudogap’ in quantum physics finally untangled

Study: Proteins in tooth enamel offer window into human wellness

New cancer cachexia treatment boosts weight gain and patient activity

Rensselaer researcher receives $3 million grant to explore gut health

Elam named as a Fellow of the Electrochemical Society

Study reveals gaps in access to long-term contraceptive supplies

Shining a light on the roots of plant “intelligence”

Scientists identify a unique combination of bacterial strains that could treat antibiotic-resistant gut infections

Pushing kidney-stone fragments reduces stones’ recurrence

[Press-News.org] Insilico Medicine Founder and CEO Alex Zhavoronkov, PhD talks about AI and robotics in healthcare breakthroughs in following conferences